These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6143058)

  • 1. High dose methylprednisolone increases plasma cyclosporin levels in renal transplant recipients.
    Klintmalm G; Säwe J
    Lancet; 1984 Mar; 1(8379):731. PubMed ID: 6143058
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of intravenous methylprednisolone with oral cyclosporin.
    Ubhi CS; Woodhouse L; Giles GR
    Nephrol Dial Transplant; 1990; 5(5):376-8. PubMed ID: 2115629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin in renal transplantation in children.
    Klare B; von Walter J; Hahn H; Emmrich P; Land W
    Lancet; 1984 Sep; 2(8404):692. PubMed ID: 6147709
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
    Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
    Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy.
    Lui SF; Sweny P; Scoble JE; Varghese Z; Moorhead JF; Fernando ON
    Nephrol Dial Transplant; 1989; 4(5):387-9. PubMed ID: 2505189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of intravenous methylprednisolone with oral CsA.
    Huisman RM; van Son WJ; Tegzess AM
    Nephrol Dial Transplant; 1990; 5(10):905-6. PubMed ID: 2128394
    [No Abstract]   [Full Text] [Related]  

  • 8. Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival.
    Langhoff E; Ladefoged J; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thaysen JH
    Lancet; 1986 Jun; 1(8493):1296-7. PubMed ID: 2872430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal of methylprednisolone at the sixth month in renal transplant recipients treated with cyclosporine.
    Cristinelli L; Brunori G; Setti G; Manganoni A; Manganoni AM; Scolari F; Sandrini S; Scaini PS; Savoldi S; Camerini C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2021-3. PubMed ID: 3079069
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract]   [Full Text] [Related]  

  • 11. [The significance of early dysfunction of the transplanted kidney].
    Filiptsev PIa; Obukh IB; Sokol'skiĭ AS; Shcherbakova EO; Ivanov IA
    Ter Arkh; 1989; 61(7):78-82. PubMed ID: 2588147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment.
    Offermann G; Keller F; Molzahn M
    Am J Nephrol; 1985; 5(5):385-7. PubMed ID: 3904451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of cyclosporin A between blood cells and plasma of cardiac and renal transplant recipients.
    Hamberger C; Urien S; Barre J; Brandebourger M; Lemaire M; Lang P; Buisson C; Loisance D; Cachera JP; Lagrue G
    Ther Drug Monit; 1988; 10(1):28-33. PubMed ID: 3287706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-to-plasma distribution of cyclosporin A in a renal transplant recipient.
    Shibata N; Minouchi T; Hayashi Y; Shibata H; Ono T; Shimakawa H
    Eur J Clin Pharmacol; 1988; 35(4):443-4. PubMed ID: 3058487
    [No Abstract]   [Full Text] [Related]  

  • 15. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 16. Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients.
    First MR; Schroeder TJ; Weiskittel P; Myre SA; Alexander JW; Pesce AJ
    Lancet; 1989 Nov; 2(8673):1198-201. PubMed ID: 2572912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convulsions associated with cyclosporin A in renal transplant recipients.
    Beaman M; Parvin S; Veitch PS; Walls J
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):139-40. PubMed ID: 3917716
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
    Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE
    S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic immunosuppressive therapy following kidney transplantation. Cyclosporin A in combination with small doses of methylprednisolone, without regard to selection criteria. Preliminary report].
    Land W; Castro LA; Hillebrand G; Illner WD; Schneider B; Siebert W; Zink R; Albert E
    Fortschr Med; 1982 Nov; 100(41):1912-6. PubMed ID: 6759336
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of nicardipine on renal function and plasma cyclosporin in renal transplant patients.
    Kessler M; Netter P; Renoult E; Jonon B; Mur JM; Trechot P; Dousset B
    Eur J Clin Pharmacol; 1989; 36(6):637-8. PubMed ID: 2673796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.